The Lancet3h
TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinoma
The advent of immunotherapy based on immune checkpoint inhibitors has improved the treatment of advanced hepatocellular ...
Monthly Prescribing Reference11h
2024 Novel Drug and Biological Product Approvals
The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.
Macrophages, not T cells, may hold key to predicting which melanoma patients are more likely to respond to immunotherapy
An international team of UK and US scientists has discovered that the activity of macrophages—a type of white blood cell that ...
Novel brain mechanism links neurotransmitters to circadian gene expression
A collaborative effort between Mount Sinai and Memorial Sloan Kettering Cancer Center has shed valuable light on how ...
Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria
Rapid onset of deep and durable clinical responses observed across multiple dosing cohorts with a favorable safety profileMean change in UAS7 ...
Science Daily8h
Cell-based therapy improves outcomes in a pig model of heart attacks
In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell spheroids derived from human induced pluripotent stem cells, or hiPSCs, that ...